No Data
No Data
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 830.45K in Common Stocks
SEC FILLINGS DISCLOSED/ May 9, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTICA
10% Of This Ligand Pharmaceuticals Insider's Holdings Were Sold
From what we can see, insiders were net sellers in Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND ) during the past 12 months. That is, insiders sold the stock in greater numbers than they purchas
10-Q: Quarterly report
Sector Update: Health Care Stocks Softer Late Afternoon
Health care stocks were slipping late Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each easing around 0.3%. The iShares Biotechnology ETF (IBB
Ligand Pharmaceuticals Shares Rise After Q1 Adjusted Earnings, Revenue Beat Views
Ligand Pharmaceuticals (LGND) shares were up nearly 11% in recent trading Wednesday, a day after the company's Q1 adjusted net income and revenue exceeded consensus. The company reported Q1 adjusted e
Earnings Call Summary | Ligand Pharmaceuticals(LGND.US) Q1 2024 Earnings Conference
The following is a summary of the Ligand Pharmaceuticals Incorporated (LGND) Q1 2024 Earnings Call Transcript:Financial Performance:Ligand Pharmaceuticals reported a Q1 2024 revenue of $31 million com